New York[email protected] | (212) 257-6039 | v-Card
Gwendolyn Melnyk is a Director in Stifel’s Global Healthcare Group who specializes in strategic transactions across North America. Gwen joined Stifel through its 2023 acquisition of Torreya.
Before joining Torreya in 2017, Gwen was an Associate in healthcare investment banking for Jefferies LLC working on sell- and buy-side M&A deals and debt and equity financings. Prior to Jefferies, she worked as a Research Associate for Regeneron Pharmaceuticals, Inc. and earlier as a Research and Development Associate for Cytimmune Sciences, Inc.
Gwen earned a B.S. in Chemical and Biomolecular engineering and an M.S. in Biotechnology from John Hopkins University. She earned an MBA in finance and management from New York University Stern School of Business.